Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Sunday, August 14, 2022.

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS)

Countertrend Up (+85) - PHAS is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.

Is it time to buy, sell, or avoid PHAS?

MarketClub looks at technical strength and momentum to determine if the timing is right for PHAS.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low PHAS Price Change
1.18 1.21 1.14 1.20 -0.01
Entry Signal

MarketClub’s Trade Triangles for PHAS

long term up The long-term trend has been UP since Aug 3rd, 2022 at 1.3199

intermediate term up The intermediate-term trend has been UP since Jul 6th, 2022 at 0.7567

short term down The short-term trend has been DOWN since Aug 10th, 2022 at 1.2000

Smart Scan Analysis for PHAS

Based on our trend formula, PHAS is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for PHAS
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
1.18 1.21 1.14 1.20 -0.01
Prev. Close Volume Bid Ask Time
1.19 125066 2022-08-12 15:58:30
Year High6Year High Date2018-10-31
Year Low2.55Year Low Date2018-11-20
52wk High4.152wk High Date2021-10-14
52wk Low0.499952wk Low Date2022-06-16
Average Volume206,623Shares Outstanding48,691
Market Cap161MAssets38,664,000M
Get a free daily analysis and signals for PhaseBio Pharmaceuticals, Inc. (PHAS) - Request Your Free Report.